EULAR-EMEUNET JC

[EULAR-EMEUNET JC @EULAR_JC]

🔔Attention! The 16th Twitter @eular_org - @EMEUNET Journal Club #EULARJC is approaching ❗️ Mark your calendars:
📆Wed Nov 3rd, 2021
⏲️7pm GMT/8pm CET
Together with @jeffsparks, we will discuss the link btw b- or ts-DMARDs use and #COVID19 severity in #RA https://t.co/HB5lmcYABU

[EMEUNET @EMEUNET]

🏆 Congratulations to Dr. John Reynolds (@Dr_JohnR) and Dr. Nophar Geifman (@NopharGeifman) for winning the EMEUNET’S CHOICE PAPER!

💻Watch the video interview about their study published in Arthritis Research & Therapy.
👉 https://t.co/IWJ8gYO7g2
👉 https://t.co/PTDUky0b9D

[EMEUNET @EMEUNET]

We congratulate Dr. John Reynolds (@Dr_JohnR) and Dr. Nophar Geifman (@NopharGeifman) for winning the EMEUNET’S CHOICE PAPER. Have you seen the video interview about their study published in Arthritis Research & Therapy?
https://t.co/IWJ8gYO7g2

https://t.co/PTDUky0b9D
#EMEUNET

[EULAR-EMEUNET JC @EULAR_JC]

Indeed, and the discussions like the one we#ve had today can only foster such collaborations! #EULARJC

[Jeffrey Sparks MD MMSc @jeffsparks]

@zach_wallace_md @EULAR_JC My take-away- great to have such great collaborators in rheumatology like @zach_wallace_md (and many others)!!!

[EULAR-EMEUNET JC @EULAR_JC]

Looking forward to see you on the next #EULARJC! Follow our updates on @EULAR_JC
@eular_org and @EMEUNET #EULARJC and follow us on Twitter, as well as the authors of today's paper in focus @zach_wallace_md @jeffsparks

[EULAR-EMEUNET JC @EULAR_JC]

Thank you all! Important topics as #COVID19, #RMDs and #DMARDs emerged, and new ideas appeared! It has been a wonderful #EULARJC edition!

[EULAR-EMEUNET JC @EULAR_JC]

A big thank you @zach_wallace_md @jeffsparks for joining us tonight/today sharing his results with the #EULARJC community!

[EULAR-EMEUNET JC @EULAR_JC]

Dear #EULARJC participants! Thank you for your curiosity, interest, and this very productive
#EULARJC. Due to restricted time, we will have to finish the conversation.

[EULAR-EMEUNET JC @EULAR_JC]

The main take-home messages from our authors @zach_wallace_md @jeffsparks #EULARJC

[Zach Wallace @zach_wallace_md]

@EULAR_JC @jeffsparks Pleasure being w/ you all. 1) RTX and JAKi pts at high risk & should continue shielding. Many are studying how to improve vaccine response & passive immunity.
2) We need add'l studies to confirm JAKi findings so interpret cautiously
3) ABA & IL6i have sim outcomes to TNFi

[EULAR-EMEUNET JC @EULAR_JC]

@zach_wallace_md @jeffsparks #EULARJC

[Jennifer Phillips @jm2phillips]

@zach_wallace_md @rheumpatient @EULAR_JC @jeffsparks #EULARJC Does this include determining whether stopping JAKi for wk after vaccine improves VE?

[EULAR-EMEUNET JC @EULAR_JC]

Since this edition of the #EULARJC is coming to a close, we need to wrap it up.
@zach_wallace_md, @jeffsparks, what are your take-home messages for this #EULARJC?

[EULAR-EMEUNET JC @EULAR_JC]

10 minutes to go! It is time to set your
final questions! #EULARJC

[Jeffrey Sparks MD MMSc @jeffsparks]

@EULAR_JC @zach_wallace_md We are ready for more! @zach_wallace_md

[EULAR-EMEUNET JC @EULAR_JC]

@zach_wallace_md @jeffsparks did you compare b- and ts-DMARDs with all-fashioned non-targeted DMARDs, like Mtx, alone? #EULARJC

[EULAR-EMEUNET JC @EULAR_JC]

Dear #EULARJC participants! We still have 15 minutes, there is still some time to send your questions to @zach_wallace_md @jeffsparks #EULARJC

[EULAR-EMEUNET JC @EULAR_JC]

@zach_wallace_md @jeffsparks Could your findings be extrapolated to other geographical areas and populations? #EULARJC

[EULAR-EMEUNET JC @EULAR_JC]

new ideas developing here! #EULARJC

[Jeffrey Sparks MD MMSc @jeffsparks]

@rheumpatient @zach_wallace_md @EULAR_JC This is a great idea for a future study! JAKi were collected as a class in the GRA so we cannot analyze that question #EULARJC

[EULAR-EMEUNET JC @EULAR_JC]

@zach_wallace_md @jeffsparks Could the better outcomes in patients treated with anti-TNFs be driven by a possible efficacy of anti-TNFs in cytokine storm syndrome due to #COVID19, as presumed previously by some papers?

[EULAR-EMEUNET JC @EULAR_JC]

A great point regarding the #COVID19 #vaccine @jeffsparks #EULARJC

[Jeffrey Sparks MD MMSc @jeffsparks]

@EULAR_JC @zach_wallace_md Certainly this is a reason to encourage RA pts (and gen population) to get vaccinated!

The pronounced risk for RTX patients and other data showing poor response to vaccine mean pts need to be counseled about shielding strategies. They need monoclonal Abs if infected #EULARJC

[EULAR-EMEUNET JC @EULAR_JC]

Another wonderful question from @rhaumpatient to @zach_wallace_md @jeffsparks. What JAK inhibitors were included in the analysis? Are they all the same? #EULARJC

[Rheumatoid Patient @rheumpatient]

@zach_wallace_md @EULAR_JC @jeffsparks May there be a difference between the JAK inhibitors, in terms of COVID-19 severity, depending on their targets i.e. JAK1/2/3? #EULARJC

[EULAR-EMEUNET JC @EULAR_JC]

@zach_wallace_md @jeffsparks Do you think a short recruitment period is a limitation? Do you plan to repeat the analysis including more data? #EULARJC